Skip to main content
SpringerLink
Log in

Prognostic Utility of a Novel Prognostic Model Consisting of Age, CRP, Ki67, and POD24 in Patients with Angioimmunoblastic T-Cell Lymphoma

  • ORIGINAL ARTICLE
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

To find the independent factors affecting the prognosis of AITL patients, establish a novel predictive model, and stratify the prognosis of AITL patients. We retrospectively analyzed the clinical data of 86 patients diagnosed with AITL in the First Affiliated Hospital of Wenzhou Medical University from December 2010 to March 2022. The clinical features, recurrence time, and death time of patients were collected and analyzed statistically. The median age of our patients was 68 years old, and the male-to-female ratio was 2.2: 1. There are differences between males and females in ECOG PS score (p = 0.037), β2 microglobulin levels (p = 0.018) and IgM (p = 0.021). Multivariate COX regression analysis showed that C-reactive protein > 39.3 mg/L (hazard ratio (HR), 5.41; p = 0.0001), Age > 66 years (hazard ratio (HR), 3.06; p = 0.0160), Ki67 positive (hazard ratio (HR), 4.86; p = 0.0010) and early progression of disease within 24 months (POD24) after diagnosis (hazard ratio (HR), 12.47; p = 0.0001) were independent factors affecting the prognosis of OS. KM analysis showed that the predictive model established by these four factors could effectively predict the prognosis of patients with AITL (p < 0.0001), and the ROC curve showed that the predictive ability of the new predictive model (AUC = 0.909) was significantly better than that of the traditional predictive models, such as IPI (AUC = 0.730), PIT (AUC = 0.720), PIAI (AUC = 0.715) and AITL score (AUC = 0.724). Age, C-reactive protein, Ki67, and POD24 were independent factors affecting the prognosis of OS. The prognostic model established by them combined clinical features, and serological and pathological indicators and could effectively predict the prognosis of AITL patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yabe M, Dogan A, Horwitz SM et al (2019) Angioimmunoblastic T-Cell Lymphoma [J]. Cancer Treat Res 176:99–126

    Article  CAS  PubMed  Google Scholar 

  2. Lunning MA, Vose JM (2017) Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma [J]. Blood 129(9):1095–1102

    Article  CAS  PubMed  Google Scholar 

  3. Federico M, Rudiger T, Bellei M et al (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project [J]. J Clin Oncol 31(2):240–246

    Article  CAS  PubMed  Google Scholar 

  4. Mourad N, Mounier N, Briere J et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials [J]. Blood 111(9):4463–4470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Feller AC, Griesser H, Schilling CV et al (1988) Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy [J]. Am J Pathol 133(3):549–556

    CAS  PubMed  PubMed Central  Google Scholar 

  6. de Leval L, Rickman DS, Thielen C et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells [J]. Blood 109(11):4952–4963

    Article  PubMed  Google Scholar 

  7. Piccaluga PP, Agostinelli C, Califano A et al (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation [J]. Cancer Res 67(22):10703–10710

    Article  CAS  PubMed  Google Scholar 

  8. Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood 127(20):2375–2390

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yuan CM, Vergilio JA, Zhao XF et al (2005) CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry [J]. Hum Pathol 36(7):784–791

    Article  CAS  PubMed  Google Scholar 

  10. Dobay MP, Lemonnier F, Missiaglia E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin [J]. Haematologica 102(4):e148–e151

    Article  PubMed  PubMed Central  Google Scholar 

  11. Willemsen M, Dielis A, Samarska IV et al (2017) A Rare Case of Angioimmunoblastic T-Cell Lymphoma with Epstein-Barr Virus-Negative Reed-Sternberg-Like B-Cells, Chylous Ascites, and Chylothorax [J]. Case Rep Hematol 2017:1279525

    PubMed  PubMed Central  Google Scholar 

  12. Vose J, Armitage J, Weisenburger D et al (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes [J]. J Clin Oncol 26(25):4124–4130

    Article  PubMed  Google Scholar 

  13. Carson KR, Horwitz SM, Pinter-Brown LC et al (2017) A prospective cohort study of patients with peripheral T-cell lymphoma in the United States [J]. Cancer 123(7):1174–1183

    Article  CAS  PubMed  Google Scholar 

  14. Schmitz N, Trumper L, Ziepert M et al (2010) Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group [J]. Blood 116(18):3418–3425

    Article  CAS  PubMed  Google Scholar 

  15. D’Amore F, Relander T, Lauritzsen GF et al (2012) Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01 [J]. J Clin Oncol 30(25):3093–3099

    Article  CAS  PubMed  Google Scholar 

  16. Advani RH, Skrypets T, Civallero M et al (2021) Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project [J]. Blood 138(3):213–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ansell SM, Habermann TM, Kurtin PJ et al (1997) Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma [J]. J Clin Oncol 15(6):2296–2301

    Article  CAS  PubMed  Google Scholar 

  18. Gallamini A, Stelitano C, Calvi R et al (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J]. Blood 103(7):2474–2479

    Article  CAS  PubMed  Google Scholar 

  19. Rudiger T, Weisenburger DD, Anderson JR et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project [J]. Ann Oncol 13(1):140–149

    Article  CAS  PubMed  Google Scholar 

  20. Buzby GP, Mullen JL, Matthews DC et al (1980) Prognostic nutritional index in gastrointestinal surgery [J]. Am J Surg 139(1):160–167

    Article  CAS  PubMed  Google Scholar 

  21. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J]. Clin Cancer Res 10(21):7252–7259

    Article  CAS  PubMed  Google Scholar 

  22. Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis [J]. J Clin Oncol 26(8):1364–1370

    Article  PubMed  Google Scholar 

  23. Ocampo-Garza J, Herz-Ruelas ME, Gonzalez-Lopez EE et al (2014) Angioimmunoblastic T-cell lymphoma: a diagnostic challenge [J]. Case Rep Dermatol 6(3):291–295

    Article  PubMed  PubMed Central  Google Scholar 

  24. Tokunaga T, Shimada K, Yamamoto K et al (2012) Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan [J]. Blood 119(12):2837–2843

    Article  CAS  PubMed  Google Scholar 

  25. Kato A, Imai Y, Aoki K et al (2014) Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma [J]. Ann Hematol 93(7):1185–1191

    Article  CAS  PubMed  Google Scholar 

  26. Yao N, Hou Q, Zhang S et al (2020) Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type [J]. Front Oncol 10:877

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yan D, Shen Z, Zhang S et al (2021) Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma [J]. J Cancer 12(23):7010–7017

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lee S, Fujita K, Morishita T et al (2021) Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma [J]. Br J Haematol 192(1):100–109

    Article  CAS  PubMed  Google Scholar 

  29. Mozas P, Rivero A, Rivas-Delgado A et al (2022) The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma [J]. Leuk Lymphoma 63(4):903–910

    Article  CAS  PubMed  Google Scholar 

  30. Herishanu Y, Perry C, Braunstein R et al (2007) Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin’s lymphoma [J]. Eur J Haematol 79(2):150–154

    Article  CAS  PubMed  Google Scholar 

  31. Rocha TM, Silva AL, Fortier SC et al (2015) Evaluation correlates C-reactive protein with advanced stage Hodgkin’s lymphoma and response to treatment in a tertiary university hospital in Brazil [J]. Rev Bras Hematol Hemoter 37(4):242–6

    Article  Google Scholar 

  32. Li Y, Yang C, Mao L et al (2017) Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor [J]. Medicine (Baltimore) 96(39):e8091

    Article  PubMed  Google Scholar 

  33. Went P, Agostinelli C, Gallamini A et al (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score [J]. J Clin Oncol 24(16):2472–2479

    Article  CAS  PubMed  Google Scholar 

  34. Cuadros M, Dave SS, Jaffe ES et al (2007) Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas [J]. J Clin Oncol 25(22):3321–3329

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, No. 342, Wenrui Avenue, Ouhai District, Wenzhou City, Zhejiang Province, China

    Yudi Wang, Suzhen Jia, Yinyan Jiang, Xiubo Cao, Shengchen Ge, Kaiqian Yang, Yi Chen & Kang Yu

  2. Department of Hematology, Shaoxing People’s Hospital, Shaoxing, China

    Yudi Wang

Authors
  1. Yudi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzhen Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yinyan Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiubo Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shengchen Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kaiqian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yi Chen or Kang Yu.

Ethics declarations

Competing Interests

The authors have declared that no competing interest exists.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Jia, S., Jiang, Y. et al. Prognostic Utility of a Novel Prognostic Model Consisting of Age, CRP, Ki67, and POD24 in Patients with Angioimmunoblastic T-Cell Lymphoma. Indian J Hematol Blood Transfus (2024). https://doi.org/10.1007/s12288-024-01767-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12288-024-01767-1

Keywords

Search

Navigation